![Mark P. Backer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark P. Backer
Direktor/Vorstandsmitglied bei
Molecular Medicine BioServices, Inc.
Profil
Mark P.
Backer is currently the Director at Molecular Medicine BioServices, Inc., a Member at American Institute of Chemical Engineers, and a Member at Parenteral Drug Association.
He previously worked as the Chairman at Genentech, Inc., Development Director at Systemix, Inc. and Coulter Pharmaceuticals, Inc., Principal at Eli Lilly & Co., MedImmune Vaccines, Inc., and IDEC Pharmaceuticals Corp., Chief Operating Officer at Vaxart, Inc., and Senior Vice President-Technical Operations at SillaJen Biotherapeutics, Inc. He also served as the Vice President-Technical Development at PDL BioPharma, Inc. from 2001 to 2005.
Dr. Backer received his undergraduate degree from Stanford University and his doctorate from the University of Washington.
Aktive Positionen von Mark P. Backer
| Unternehmen | Position | Beginn |
|---|---|---|
Molecular Medicine BioServices, Inc.
 Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Direktor/Vorstandsmitglied | - |
Parenteral Drug Association
 Parenteral Drug Association Miscellaneous Commercial ServicesCommercial Services Operates as a scientific membership association that connects professionals in pharmaceutical science and regulation by offering global conferences, training courses, technical publications | Corporate Officer/Principal | - |
American Institute of Chemical Engineers
 American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mark P. Backer
| Unternehmen | Position | Ende |
|---|---|---|
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 30.12.2005 |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | - |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Corporate Officer/Principal | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Corporate Officer/Principal | - |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Corporate Officer/Principal | - |
Ausbildung von Mark P. Backer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Molecular Medicine BioServices, Inc.
Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Health Technology |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
American Institute of Chemical Engineers
American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Commercial Services |
Parenteral Drug Association
Parenteral Drug Association Miscellaneous Commercial ServicesCommercial Services Operates as a scientific membership association that connects professionals in pharmaceutical science and regulation by offering global conferences, training courses, technical publications | Commercial Services |
